The Journal of Minimally Invasive Gynecology
Volume 16, Issue 5 , Pages 527-532, September 2009

Perivascular Epithelioid Cell Neoplasms: A Systematic Review of Prognostic Factors

  • Nazila Zekry, MD

      Affiliations

    • Hoag Memorial Hospital, Department of Pathology, Newport Beach, CA
  • ,
  • Mark A. Rettenmaier, MD

      Affiliations

    • Gynecologic Oncology Associates, Hoag Cancer Center, Newport Beach, CA
  • ,
  • Lisa N. Abaid, MD

      Affiliations

    • Gynecologic Oncology Associates, Hoag Cancer Center, Newport Beach, CA
  • ,
  • Cameron R. John, PhD

      Affiliations

    • Department of Behavioral Sciences, Utah Valley University, Orem, UT
  • ,
  • John P. Micha, MD

      Affiliations

    • Gynecologic Oncology Associates, Hoag Cancer Center, Newport Beach, CA
  • ,
  • John V. Brown III, MD

      Affiliations

    • Gynecologic Oncology Associates, Hoag Cancer Center, Newport Beach, CA
  • ,
  • Bram H. Goldstein, PhD

      Affiliations

    • Gynecologic Oncology Associates, Hoag Cancer Center, Newport Beach, CA
    • Corresponding Author InformationCorresponding author: Bram Goldstein, PhD, Gynecologic Oncology Associates, 351 Hospital Road, Suite 507, Newport Beach, CA 92663.

Received 24 February 2009; accepted 30 April 2009. published online 14 July 2009.

Abstract 

Perivascular epithelioid cell tumors (PEComas) are rare, soft tissue tumors characterized by epithelioid cells with clear or eosinophilic cytoplasm and a perivascular disbursement. We compiled the treatment and follow-up results from an extensive collection of reported gynecologic PEComa cases and statistically analyzed their respective therapy modalities and corresponding patient outcomes. In the group of patients with PEComa who received surgical management alone, there was a tendency for them to exhibit a lower disease recurrence rate. Conversely, patients with PEComa who initially received surgery and chemotherapy or radiation therapy were associated with a higher disease recurrence rate (P =.024). Metastatic involvement was related to higher patient mortality rates (P =.0001), although this finding was unrelated to treatment type. Surgical management alone may suffice for nonaggressive lesions, but chemotherapy and radiotherapy appear necessary for patients who present with high-risk histologic condition or metastatic disease. Because PEComas exhibit varying biologic behavior and an ill-defined presentation, the treatment for these lesions necessitates further evaluation.

Keywords: Perivascular epithelioid cell tumors, Treatment, Gynecologic oncology, Pathology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

PII: S1553-4650(09)00237-4

doi:10.1016/j.jmig.2009.04.017

The Journal of Minimally Invasive Gynecology
Volume 16, Issue 5 , Pages 527-532, September 2009